Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Pill Makes Chemotherapy Easier to Swallow

WebMD Health News
Reviewed by Gary D. Vogin, MD

April 18, 2001 -- Colon cancer patients may soon take their chemotherapy in a pill, at home, rather than through an IV, at the hospital. Xeloda is a new oral formulation of 5-FU, the most commonly used colon cancer treatment. And in a recent clinical trial, it was just as effective as its intravenous counterpart, with far fewer side effects.

Want to chat with others about colon cancer? Join our member community on Colorectal Cancer.

The chemotherapy pill "is both convenient to use and produces fewer side effects, and that's a big attraction for patients. Given these results, patients slated to receive the chemotherapy drug 5-FU could consider receiving it in pill form rather than through an IV," said study leader Paulo M. Hoff, MD, in a written statement.

Hoff's international research team randomly assigned more than 600 advanced colon cancer patients to receive a standard course of Xeloda or traditional intravenous 5-FU plus another chemotherapy drug called Wellcovorin. Their findings are published in the April 15 issue of the Journal of Clinical Oncology.

About 25% of patients treated with Xeloda responded to therapy, meaning that their tumors shrank, compared with 16% of standard therapy patients. What's more, the Xeloda patients experienced significantly less diarrhea, nausea, gastrointestinal ulcers, and hair loss than did the group receiving standard therapy.

Inexplicably, the tumor shrinkage did not translate to longer life. Even so, says Hoff, "a good tumor response is reassuring for patients, and may ultimately benefit them." Because it is better tolerated than IV chemotherapy -- and can be taken in the comfort and privacy of a patient's own home -- the new pill may improve quality of life.

But Banke Agarwal, MD, who reviewed the research for WebMD, urges caution.

"These drugs can carry serious adverse reactions. If you're in the hospital, the doctor can identify and treat them, then and there. At home, a patient needs to know exactly what to look out for and what to do. This would require very good patient education," he tells WebMD. Agarwal is an assistant professor of medicine at the University of Texas M.D. Anderson Cancer Center in Houston.

Xeloda manufacturer Hoffman-La Roche Inc. provided partial funding for the study.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas